Skip to main content

Judge Reverses Mandatory Vaccination Order In Opioid Trials

Judge Reverses Mandatory Vaccination Order In Opioid Trials

Judge Reverses Mandatory Vaccination Order In Opioid Trials

Introduction

An Ohio federal judge has issued a fresh order that states the potential jurors in the national multidistrict opioid litigation are not required to be vaccinated against COVID-19 to attend the court ruling.

Earlier, U.S. District Judge Dan Aaron Polster ordered that all the jurors of the upcoming opioid trials need to be vaccinated on a mandatory basis, but a bid from various pharmacy defendants including Walgreens, CVS, and Rite Aid compelled the judge to reverse the decision.

The judge considered the pharmacies' argument that the vaccination rates vary by race, gender, and political views that might result in delayed vaccination for the jurors, which could eventually result in a delay in resolving the lawsuits as many jurors would miss the rulings. The pharmacies even argued that if the jurors are limited to only those who are fully vaccinated, it could impact the outcomes of the trials.

Even though the mandatory vaccination clause has been eliminated, the judge has encouraged the attorneys and the witnesses to get vaccinated at the earliest. As per the motion presented by the pharmacies, 42.6% population of the state has been fully vaccinated as of June 16, according to the report of Ohio's Department of Health.

The first pharmacy bellwether trial will begin on Oct. 4, and the jury selection for the same will begin on Sept. 29 and continue through Oct. 1, as stated in the judge's order. The trial will focus on two Ohio counties' claims of the public nuisance created by the pharmacy chains like CVS and Rite Aid, who ignored the suspiciously bulk orders of opioids.

Earlier, the focus of the opioid MDL was on drugmakers and distributors but has recently shifted to pharmacies, as the companies are working on settling the claims against them.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!